Bosentan Sulfoxide

Bosentan Sulfoxide or 4-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidine-4-yl)benzenesulfinamide is the associate impurity of Bosentan. Bosentan is a dual endothelin receptor antagonist. Bosentan is employed to treat pulmonary hypertension by blocking the action of endothelin molecules.

Additional information

Catalogue No.

VE007406

CAS No.

N/A

Molecular Formula

C27H29N5O5S

Molecular Weight

535.61 g/mol

IUPAC Name

4-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)benzenesulfinamide

References

“Sci-Hub, Bosentan Therapy for Portopulmonary Hypertension, 10.1183/09031936.05.00080804.” Hkvisa.net, 2022, sci-hub.hkvisa.net/10.1183/09031936.05.00080804.

Status

In-stock